Income Statement CannaPharmaRX, Inc.

Stocks

CPMD

US13765D1090

Healthcare Facilities & Services

Delayed OTC Markets 10:47:48 2026-09-17 EDT			5-day change	1st Jan Change
0.002000 ^USD	0.00%		-16.67%	-61.54%

08-18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

dfe8.gwsrS8-7NO2kZptjkruFCIKc3Kkmkr-kp_OxpM9i6Mw.wFJoO5bPWa_GEf8U5fHcONH_iPpF3N7L1buGlp0Ar7jEZVMm_Ihr3pIIow

Published financial data: CANNAPHARMARX, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	-	-	-	820K	1.36M
Total Revenues	-	-	-	820K	1.36M
Cost of Goods Sold, Total	-	-	65.56K	3.78M	3.75M
Gross Profit	-	-	-65.56K	-2.96M	-2.39M
Selling General & Admin Expenses, Total	2.25M	4.74M	1.28M	598K	959K
Stock-Based Compensation (IS)	363K	181K	-	-	-
Depreciation & Amortization - (IS)	2.71K	295K	128K	-	-
Other Operating Expenses	-	-	100K	50.99K	-
Other Operating Expenses, Total	2.62M	5.21M	1.51M	649K	959K
Operating Income	-2.62M	-5.21M	-1.58M	-3.61M	-3.35M
Interest Expense, Total	-1.51M	-2.29M	-1.7M	-2.27M	-2.45M
Net Interest Expenses	-1.51M	-2.29M	-1.7M	-2.27M	-2.45M
Currency Exchange Gains (Loss)	-	-	-	-	66.25K
Other Non Operating Income (Expenses)	3.17M	-98.98K	146K	-3.34M	1.05M
EBT, Excl. Unusual Items	-955K	-7.6M	-3.13M	-9.22M	-4.68M
Merger & Related Restructuring Charges	-377K	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-6.67M	-	-78.76K	-	-4.52M
Gain (Loss) On Sale Of Assets	624K	-	-	-	-
Other Unusual Items	-1.45M	-930K	6.89M	-691K	-1.93M
EBT, Incl. Unusual Items	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Earnings From Continuing Operations	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Net Income to Company	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Net Income - (IS)	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Net Income to Common Incl Extra Items	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Net Income to Common Excl. Extra Items	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Per Share Items
Net EPS - Basic	-0.12	-0.04	0.01	-0.02	-0.02
Basic EPS - Continuing Operations	-0.12	-0.04	0.01	-0.02	-0.02
Basic Weighted Average Shares Outstanding	74.69M	211M	309M	625M	663M
Net EPS - Diluted	-0.12	-0.04	0.01	-0.02	-0.02
Diluted EPS - Continuing Operations	-0.12	-0.04	0.01	-0.02	-0.02
Diluted Weighted Average Shares Outstanding	74.69M	211M	309M	625M	663M
Normalized Basic EPS	-0.01	-0.02	-0.01	-0.01	-0
Normalized Diluted EPS	-0.01	-0.02	-0.01	-0.01	-0
Supplemental Items
EBITDA	-2.61M	-4.92M	-1.45M	-3.48M	-
EBITA	-2.62M	-5.21M	-1.58M	-3.61M	-3.35M
EBIT	-2.62M	-5.21M	-1.58M	-3.61M	-3.35M
EBITDAR	-2.6M	-4.9M	-1.44M	-3.47M	-
Normalized Net Income	-597K	-4.75M	-1.95M	-5.76M	-2.93M
Interest on Long-Term Debt	-	927K	963K	981K	1M
Supplemental Operating Expense Items
Advertising Expense	-	-	28.82K	-	-
Marketing Expenses	-	-	-	-	71.29K
Selling and Marketing Expenses	-	-	28.82K	-	71.29K
General and Administrative Expenses	2.24M	4.71M	838K	593K	886K
Net Rental Expense, Total	14.36K	12.31K	2.6K	4.38K	2.12K
Imputed Operating Lease Interest Expense	18.21K	19.16K	2.57K	5.88K	2.4K
Imputed Operating Lease Depreciation	-3.85K	-6.85K	29	-1.5K	-274
Maintenance & Repair Expenses, Total	-	-	65.56K	21.73K	-
Stock-Based Comp., Other (Total)	574K	298K	-	-	-
Total Stock-Based Compensation	574K	298K	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	27.77K	2.32K	650	2.16K	1.8K
Total Cash And Short Term Investments	27.77K	2.32K	650	2.16K	1.8K
Accounts Receivable, Total	-	-	-	1.75K	164K
Other Receivables	1.77K	23.25K	61.52K	18.71K	29.83K
Total Receivables	1.77K	23.25K	61.52K	20.45K	194K
Inventory	-	-	1.13M	996K	1.12M
Prepaid Expenses	-	68.54K	-	-	-
Other Current Assets, Total	-	5.91K	-	-	-
Total Current Assets	29.54K	100K	1.2M	1.02M	1.31M
Gross Property Plant And Equipment	11.15K	5.52M	6.08M	6.16M	-
Accumulated Depreciation	-5.12K	-288K	-47.91K	-862K	-
Net Property Plant And Equipment	6.03K	5.24M	6.03M	5.3M	5.71M
Long-term Investments	78.76K	78.76K	4.52M	4.52M	-
Goodwill	-	-	-	-	-
Other Intangibles, Total	-	-	-	-	-
Total Assets	114K	5.41M	11.75M	10.84M	7.02M
Liabilities
Accounts Payable, Total	3.13M	6.88M	5.59M	4.78M	5.47M
Accrued Expenses, Total	194K	152K	872K	6.8M	6.42M
Short-term Borrowings	795K	1.22M	6.68M	4.47M	1.19M
Current Portion of Long-Term Debt	8.22M	7.72M	334K	3.97M	12.88M
Current Portion of Leases	-	-	190K	728K	1M
Unearned Revenue Current, Total	-	-	-	-	261K
Other Current Liabilities	697K	1.2M	4.5M	5M	4.37M
Total Current Liabilities	13.04M	17.17M	18.16M	25.75M	31.59M
Long-Term Debt	-	-	-	-	549K
Long-Term Leases	-	5.59M	5.73M	4.89M	5.03M
Other Non Current Liabilities	-1	-	-	-	-
Total Liabilities	13.04M	22.76M	23.9M	30.65M	37.17M
Preferred Stock Convertible	542K	2.56M	3.29M	629K	629K
Total Preferred Equity	542K	2.56M	3.29M	629K	629K
Common Stock, Total	12.55K	27.41K	44.08K	66.25K	66.25K
Additional Paid In Capital	73.06M	74.52M	75.83M	80.12M	81.52M
Retained Earnings	-86.16M	-94.7M	-91.28M	-101M	-112M
Treasury Stock	-13	-13	-	-	-
Comprehensive Income and Other	-372K	240K	-35.02K	556K	-54.45K
Total Common Equity	-13.47M	-19.9M	-15.44M	-20.44M	-30.78M
Total Equity	-12.93M	-17.34M	-12.15M	-19.81M	-30.15M
Total Liabilities And Equity	114K	5.41M	11.75M	10.84M	7.02M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	166M	299M	656M	656M	672M
ECS Total Common Shares Outstanding	125M	274M	435M	656M	656M
Book Value / Share	-0.11	-0.07	-0.04	-0.03	-0.05
Tangible Book Value	-13.47M	-19.9M	-15.44M	-20.44M	-30.78M
Tangible Book Value Per Share	-0.11	-0.07	-0.04	-0.03	-0.05
Total Debt	9.02M	14.52M	12.94M	14.06M	20.65M
Net Debt	8.99M	14.52M	12.93M	14.06M	20.65M
Debt Equivalent Oper. Leases	115K	98.46K	20.79K	35.05K	16.99K
Account Code - Inventory Valuation	-	3	3	3	6
Inventories - Work In Process, Total	-	-	661K	1.56M	774K
Inventories - Finished Goods, Total	-	-	472K	752K	828K
Land - (BS)	-	-	-	-	-
Machinery, Total	11.15K	126K	209K	211K	-
Full Time Employees	4	6	21	26	26
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	21.19K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-8.83M	-8.53M	3.69M	-9.91M	-11.13M
Depreciation & Amortization - CF	2.71K	295K	128K	-	-
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	2.71K	295K	128K	-	-
Amortization of Deferred Charges, Total - (CF)	1.26M	479K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	6.67M	-	78.76K	-	4.52M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	363K	181K	-	-	-
Other Operating Activities, Total	-1.45M	2.18M	-5.35M	8.18M	5.39M
Change In Accounts Receivable	-	-	-	-1.75K	-1.01M
Change In Inventories	-	-	-1.13M	-508K	-1.99M
Change In Accounts Payable	-450K	1.42M	130K	764K	2.88M
Change in Unearned Revenues	-	-	-	-	261K
Change in Other Net Operating Assets	28.68K	2.53M	182K	-230K	292K
Cash from Operations	-2.41M	-1.45M	-2.27M	-1.7M	-789K
Capital Expenditure	-6.26K	-116K	-80.63K	-	-5.52K
Sale of Property, Plant, and Equipment	539K	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Cash from Investing	533K	-116K	-80.63K	-	-5.52K
Short Term Debt Issued, Total	584K	968K	2.35M	150K	-
Long-Term Debt Issued, Total	239K	-	-	1.55M	794K
Total Debt Issued	823K	968K	2.35M	1.7M	794K
Short Term Debt Repaid, Total	-309K	-	-	-	-
Total Debt Repaid	-309K	-	-	-	-
Issuance of Common Stock	291K	437K	-	-	-
Repurchase of Common Stock	-39.49K	-	-	-	-
Issuance of Preferred Stock	535K	-	-	-	-
Cash from Financing	1.3M	1.4M	2.35M	1.7M	794K
Foreign Exchange Rate Adjustments	273K	134K	-	-	-
Miscellaneous Cash Flow Adjustments	-	1	-	-	-
Net Change in Cash	-307K	-25.45K	-1.67K	1.51K	-352
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-4.15M	383K	-1.29M	2.13M	-3.98M
Unlevered Free Cash Flow	-4.46M	1.34M	-228K	3.55M	-2.45M
Change In Net Working Capital	3.4M	-4.12M	-709K	-5.8M	356K
Net Debt Issued / Repaid	514K	968K	2.35M	1.7M	794K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-36.91	-117.84	-10.89	-19.96	-23.44
Return on Total Capital	120.8	96.85	96.64	90.73	27.44
Return On Equity %	81.3	56.37	-25.01	61.98	44.56
Return on Common Equity	77.46	51.13	-20.87	56.23	43.46
Margin Analysis
Gross Profit Margin %	-	-	-	-360.51	-175.34
SG&A Margin	-	-	-	72.86	70.43
EBITDA Margin %	-	-	-	-424	-
EBITA Margin %	-	-	-	-439.59	-245.77
EBIT Margin %	-	-	-	-439.59	-245.77
Income From Continuing Operations Margin %	-	-	-	-1.21K	-817.19
Net Income Margin %	-	-	-	-1.21K	-817.19
Net Avail. For Common Margin %	-	-	-	-1.21K	-817.19
Normalized Net Income Margin	-	-	-	-702.25	-214.88
Levered Free Cash Flow Margin	-	-	-	259.84	-292.53
Unlevered Free Cash Flow Margin	-	-	-	432.46	-180.14
Asset Turnover
Asset Turnover	-	-	-	0.07	0.15
Fixed Assets Turnover	-	-	-	0.14	0.25
Receivables Turnover (Average Receivables)	-	-	-	-	16.39
Inventory Turnover (Average Inventory)	-	-	-	3.55	3.55
Short Term Liquidity
Current Ratio	0	0.01	0.07	0.04	0.04
Quick Ratio	0	0	0	0	0.01
Operating Cash Flow to Current Liabilities	-0.19	-0.08	-0.13	-0.07	-0.02
Days Sales Outstanding (Average Receivables)	-	-	-	-	22.26
Days Outstanding Inventory (Average Inventory)	-	-	-	103.2	102.75
Average Days Payable Outstanding	-	-	-	488.41	483.59
Cash Conversion Cycle (Average Days)	-	-	-	-	-358.58
Long Term Solvency
Total Debt/Equity	-69.78	-83.74	-106.44	-70.98	-68.48
Total Debt / Total Capital	-230.85	-515.15	1.65K	-244.56	-217.29
LT Debt/Equity	-	-32.25	-47.19	-24.7	-18.51
Long-Term Debt / Total Capital	-	-198.38	733.19	-85.1	-58.74
Total Liabilities / Total Assets	11.41K	420.35	203.47	282.82	529.64
EBIT / Interest Expense	-1.74	-2.28	-0.93	-1.59	-1.37
EBITDA / Interest Expense	-1.73	-2.15	-0.85	-1.54	-1.37
(EBITDA - Capex) / Interest Expense	-1.74	-2.2	-0.9	-1.54	-1.37
Total Debt / EBITDA	-3.45	-2.95	-8.94	-4.04	-6.17
Net Debt / EBITDA	-3.44	-2.95	-8.94	-4.04	-6.17
Total Debt / (EBITDA - Capex)	-3.44	-2.89	-8.47	-4.04	-6.16
Net Debt / (EBITDA - Capex)	-3.43	-2.89	-8.47	-4.04	-6.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	66.09
Gross Profit, 1 Yr. Growth %	-	-	127.79	4.41K	-18.62
EBITDA, 1 Yr. Growth %	-42.04	88.11	-70.54	140.26	-
EBITA, 1 Yr. Growth %	-42	99.19	-69.76	128.88	-7.8
EBIT, 1 Yr. Growth %	-43.59	99.19	-69.76	128.88	-7.8
Earnings From Cont. Operations, 1 Yr. Growth %	-55.59	-3.41	-143.24	-368.56	12.37
Net Income, 1 Yr. Growth %	-55.59	-3.41	-143.24	-368.56	12.37
Normalized Net Income, 1 Yr. Growth %	-91	696.17	-58.88	194.81	-49.18
Diluted EPS Before Extra, 1 Yr. Growth %	-75.8	-65.82	-124.74	-232.69	6.06
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	9.31K
Inventory, 1 Yr. Growth %	-	-	-	-12.12	11.95
Net Property, Plant and Equip., 1 Yr. Growth %	-99.62	86.69K	-2.06	-12.15	7.71
Total Assets, 1 Yr. Growth %	-98.69	4.64K	85.35	-7.75	-35.23
Tangible Book Value, 1 Yr. Growth %	44.25	47.79	-22.41	38.17	50.61
Common Equity, 1 Yr. Growth %	44.25	47.79	-22.41	38.17	50.61
Cash From Operations, 1 Yr. Growth %	328.45	-40.02	57.04	-25.38	-53.51
Capital Expenditures, 1 Yr. Growth %	-	1.75K	-30.49	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-158.61	-109.24	-198.64	-265.39	-288.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-171.77	-129.95	-110.08	-1.66K	-169.5
Compound Annual Growth Rate Over Two Years
Gross Profit, 2 Yr. CAGR %	-	-	-	913.56	503.58
EBITDA, 2 Yr. CAGR %	-4.26	4.42	-25.59	-15.87	-
EBITA, 2 Yr. CAGR %	-4.22	7.48	-22.41	-16.8	45.78
EBIT, 2 Yr. CAGR %	-6.3	6	-22.41	-16.8	45.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-34.28	-34.51	-35.38	7.76	73.72
Net Income, 2 Yr. CAGR %	-34.28	-34.51	-35.38	7.76	73.72
Normalized Net Income, 2 Yr. CAGR %	-64.21	-15.35	80.94	10.11	22.4
Diluted EPS Before Extra, 2 Yr. CAGR %	-57.54	-71.24	-70.92	-37.4	18.63
Inventory, 2 Yr. CAGR %	-	-	-	-	-0.81
Net Property, Plant and Equip., 2 Yr. CAGR %	-94.02	82.68	3.06K	-7.24	-2.73
Total Assets, 2 Yr. CAGR %	-91.55	-21.33	913.58	30.76	-22.7
Tangible Book Value, 2 Yr. CAGR %	86.18	46.01	7.08	1.34	44.26
Common Equity, 2 Yr. CAGR %	76.58	46.01	7.08	1.34	44.26
Cash From Operations, 2 Yr. CAGR %	-20.23	60.31	-2.95	8.25	-41.1
Capital Expenditures, 2 Yr. CAGR %	-63.47	-	258.81	-	-73.84
Levered Free Cash Flow, 2 Yr. CAGR %	187.29	-76.72	-44.26	27.72	75.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.32	-53.64	-77.39	25.24	228.08
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	-	-	-	336.18
EBITDA, 3 Yr. CAGR %	-	19.92	-31.53	9.98	-
EBITA, 3 Yr. CAGR %	69.98	22.26	-29.58	11.28	-13.7
EBIT, 3 Yr. CAGR %	69.98	20.48	-30.23	11.28	-13.7
Earnings From Cont. Operations, 3 Yr. CAGR %	41.85	-25.28	-42.97	3.9	9.27
Net Income, 3 Yr. CAGR %	41.85	-25.28	-42.97	3.9	9.27
Normalized Net Income, 3 Yr. CAGR %	-29.05	0.66	-33.46	112.92	-14.91
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.78	-60.5	-72.65	-48.83	-25.37
Net Property, Plant and Equip., 3 Yr. CAGR %	-84.32	45.83	56.66	857.72	-2.5
Total Assets, 3 Yr. CAGR %	-77.55	-30.34	10.32	355.93	3.46
Tangible Book Value, 3 Yr. CAGR %	17.59	72.39	18.26	14.92	15.64
Common Equity, 3 Yr. CAGR %	238.81	66.41	18.26	14.92	15.64
Cash From Operations, 3 Yr. CAGR %	36.9	-27.46	59.21	-11.09	-18.33
Capital Expenditures, 3 Yr. CAGR %	-	35.2	-	-	-63.76
Levered Free Cash Flow, 3 Yr. CAGR %	-	-8.62	-43.32	-19.91	45.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-14.55	-66.78	-7.36	2.76
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	21.36	-	-	4.05	-
EBITA, 5 Yr. CAGR %	21.09	279.36	24.21	4.8	-5.79
EBIT, 5 Yr. CAGR %	21.09	279.36	24.21	3.88	-6.31
Earnings From Cont. Operations, 5 Yr. CAGR %	54.56	318.66	3.58	-13.5	-10.96
Net Income, 5 Yr. CAGR %	54.56	318.66	3.58	-13.5	-10.96
Normalized Net Income, 5 Yr. CAGR %	-0.95	309.1	3.18	4.33	-15.09
Diluted EPS Before Extra, 5 Yr. CAGR %	16.23	155.81	-43.41	-52.51	-49.04
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	31	25.71	29.47
Total Assets, 5 Yr. CAGR %	132.94	-	3.07	-7.52	-4.31
Tangible Book Value, 5 Yr. CAGR %	69.68	83.21	13.27	39.38	26.95
Common Equity, 5 Yr. CAGR %	69.68	83.21	113.72	36.46	26.95
Cash From Operations, 5 Yr. CAGR %	155.03	-	19.3	-14.86	6.96
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	63.91	-	-	33.5	-10.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	66.29	-	-	10.62	-16.96